AM-Pharma’s €245 Million License Agreement With Kyowa Kirin

Stephenson Harwood LLP has advised AM-Pharma on the deal.AM-Pharma signed a €245 million exclusive license agreement deal with Kyowa Kirin, for the development and commercialisation of…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Giulia Di Palma

Author: Giulia Di Palma

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here